<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HD9C5C5A7ABE2428A8F006E3B7FFE1518" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>111th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 5888</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20100727">July 27, 2010</action-date>
			<action-desc><sponsor name-id="M001149">Mr. Michaud</sponsor> (for
			 himself, <cosponsor name-id="P000597">Ms. Pingree of Maine</cosponsor>, and
			 <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To establish an America Rx program to establish fairer
		  pricing for prescription drugs for individuals without access to prescription
		  drugs at discounted prices.</official-title>
	</form>
	<legis-body id="H4308AA7966B849C58E9D0D295A4C8A10" style="OLC">
		<section display-inline="no-display-inline" id="HBAE30EEA067D41F7B0A2A4C2C8265381" section-type="section-one"><enum>1.</enum><header>Short title; purpose</header>
			<subsection id="H6D93D825001A4052877A3D21C697B085"><enum>(a)</enum><header>Short
			 title</header><text>This Act may be cited as the <quote><short-title>America Rx Act of 2010</short-title></quote>.</text>
			</subsection><subsection id="HA0E1B36A29E04B31A563131BFA8EA6CA"><enum>(b)</enum><header>Purpose</header><text>The
			 purpose of this Act is to establish an America Rx program that utilizes
			 manufacturer rebates and pharmacy discounts to reduce prescription drug prices
			 to those residents who are without access to discounted prices for outpatient
			 prescription drugs.</text>
			</subsection></section><section id="H74A882BFCE204F3499D6DC381C9A2270"><enum>2.</enum><header>America Rx
			 program</header>
			<subsection id="H185818F3FA8D4B929C330D89996328AD"><enum>(a)</enum><header>Establishment</header>
				<paragraph id="HBAC224BA696E454DBCCA3B69EBA5AF71"><enum>(1)</enum><header>In
			 general</header><text>Not later than 1 year after the date of the enactment of
			 this Act, the Secretary of Health and Human Services shall establish a program
			 (in this section referred to as the <quote>America Rx program</quote>)
			 consistent with the provisions of this section to provide qualified residents
			 with access to discounted prices for outpatient prescription drugs through
			 rebate agreements that the Secretary has negotiated with prescription drug
			 manufacturers.</text>
				</paragraph><paragraph commented="no" id="H3850CE93B59649AB88C81C7F7CF16889"><enum>(2)</enum><header>Outreach</header><text>The
			 Secretary shall provide for—</text>
					<subparagraph commented="no" id="HEF4C2DE623624850B74238D5A6A371C1"><enum>(A)</enum><text>outreach efforts
			 to build public awareness of the program and maximize enrollment of qualified
			 residents; and</text>
					</subparagraph><subparagraph commented="no" id="HA3F555C201344C18ADE3EB899DA5494D"><enum>(B)</enum><text>simplified
			 eligibility procedures and uniform eligibility standards for qualified
			 residents.</text>
					</subparagraph></paragraph></subsection><subsection id="H117D71577BF247438FA031B938A6FC59"><enum>(b)</enum><header>Rebate
			 agreements with manufacturers</header>
				<paragraph id="HEC63ABAF56DD4FA6B6992BE02E3A23A6"><enum>(1)</enum><header>In
			 general</header><text>Under the America Rx program the Secretary shall
			 negotiate with manufacturers of outpatient prescription drugs rebate agreements
			 with respect to drugs offered under the program to qualified residents.</text>
				</paragraph><paragraph id="H7744F2E8B9B14DCC968819EAF55C9C2B"><enum>(2)</enum><header>Minimum amount
			 of rebates</header><text>In negotiating the amount of such a rebate under
			 paragraph (1), the Secretary shall take into consideration the amount of the
			 rebate calculated under the Medicaid program, the average manufacturer price of
			 prescription drugs, and other information on prescription drug prices and price
			 discounts. The Secretary shall negotiate the amount of such rebates in a manner
			 so that the rebates on average are comparable to the average percentage rebate
			 obtained in outpatient prescription drugs provided under section 1927(c) of the
			 <act-name parsable-cite="SSA">Social Security Act</act-name> (42 U.S.C.
			 1396r–8(c)).</text>
				</paragraph><paragraph display-inline="no-display-inline" id="H13660CB2CBF44A2D86F88D02D4DE46CC"><enum>(3)</enum><header>Discounted
			 prices</header><text display-inline="yes-display-inline">The Secretary shall
			 specify the method for computing and applying such discounts, including a
			 method for computing and applying discounts on a uniform, average percentage
			 basis.</text>
				</paragraph><paragraph id="H7B0A8A9E499147759630D30FA90E0FEA"><enum>(4)</enum><header>Payment</header><text>Rebates
			 under such agreements shall be payable to the Secretary according to a schedule
			 (not less often than quarterly) negotiated with manufacturers and shall be
			 paid, directly or through States, to participating pharmacies that provide
			 discounts to qualified residents.</text>
				</paragraph><paragraph id="H736ED7864D6B449DAD4F35AED04AF399"><enum>(5)</enum><header>Incentive</header><text>In
			 order to induce manufacturers of outpatient prescription drugs to enter into
			 such rebate agreements to carry out the purpose described in section 1(b), the
			 Secretary shall provide, in the case of a manufacturer that has not entered
			 into such an agreement, for a denial of a deduction under chapter 1 of the
			 Internal Revenue Code of 1986 for the amount of expenses of the manufacturer
			 for advertising and marketing of drugs of the manufacturer, other than expenses
			 for free samples of drugs subject to section 503(b)(1) of the Federal Food
			 Drug, and Cosmetic Act intended to be distributed to patients.</text>
				</paragraph><paragraph id="H54501A6A794B4DD4857FEEDFAE14475A"><enum>(6)</enum><header>Application of
			 rebates</header><text display-inline="yes-display-inline">Amounts received by
			 the Secretary as rebates under this subsection shall be placed into an
			 appropriate account in the Treasury and shall be available in advance of
			 appropriations to the Secretary for the payment of discounts and other costs of
			 participating pharmacies in carrying out the America Rx program and for the
			 payment of administrative costs in carrying out the program. Under the America
			 Rx program, participating pharmacies shall be ensured reasonable and timely
			 payment of discounts they provide to qualified residents under the
			 program.</text>
				</paragraph></subsection><subsection id="H8C7A71E0A9C24DEAB2B6BAF2D493813E"><enum>(c)</enum><header>Role of States
			 in administering program</header>
				<paragraph id="HD1C71679DA154131A804FCA54A4470B1"><enum>(1)</enum><header>In
			 general</header><text>Under the America Rx program the Secretary may enter into
			 appropriate arrangements with States under which States provide for the
			 administration of the program in return for payment of the reasonable
			 administrative expenses associated with such administration.</text>
				</paragraph><paragraph id="HDDB79FE83CC049488E77B382069CB0AC"><enum>(2)</enum><header>Administrative
			 functions</header><text>Such administration functions may include—</text>
					<subparagraph id="H4E6BCE389B9A464882A6EF5802A90829"><enum>(A)</enum><text>determinations of
			 eligibility of qualified residents;</text>
					</subparagraph><subparagraph id="H115B7078F7C54508B381D7C694B04DC1"><enum>(B)</enum><text>arrangements with
			 participating pharmacies; and</text>
					</subparagraph><subparagraph id="HD63AAE4FE29A4971BC0676FB0A8FA164"><enum>(C)</enum><text>such other
			 functions as the Secretary determines appropriate.</text>
					</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H4196A140374B423980AA7287AAC64774"><enum>(3)</enum><header>Contractual
			 authority</header><text>In carrying out responsibilities under this section,
			 the Secretary and States may enter into agreements with pharmacy benefit
			 managers and other third parties.</text>
				</paragraph></subsection><subsection id="HABC6AA8FD954435B8418B01E33ACB1A9"><enum>(d)</enum><header>Program
			 eligibility</header>
				<paragraph id="HFAB042F56FD2480C8CE6E79A2B231D68"><enum>(1)</enum><header>Qualified
			 resident defined</header><text>For purposes of this section, the term
			 <term>qualified resident</term> means an individual who—</text>
					<subparagraph id="H0ECA56065D814EC79545AA1AA5F4716A"><enum>(A)</enum><text display-inline="yes-display-inline">is a citizen or national of the United
			 States or is lawfully present in the United States (as determined in accordance
			 with section 1411 of the Patient Protection and Affordable Care Act);
			 and</text>
					</subparagraph><subparagraph id="H7560B43ADC5A4ADA8A098EABF2E4A574"><enum>(B)</enum><text>as determined
			 under regulations of the Secretary, is not covered under any public or private
			 program that provides substantial benefits (which may be discounted prices)
			 towards the purchase of outpatient prescription drugs.</text>
					</subparagraph></paragraph><paragraph id="H73994195A9C24B4B9D4EFB7A78DB4092"><enum>(2)</enum><header>Screening</header>
					<subparagraph id="HDF4EF3AF6DBB49CFABC68D97AC674C80"><enum>(A)</enum><header>For other
			 governmental programs</header><text>Individuals who apply for benefits under
			 the America Rx program shall be screened for eligibility under the Medicaid
			 program and other applicable Governmental health care programs and, if found
			 eligible, shall be enrolled in such program or programs.</text>
					</subparagraph><subparagraph id="H06E364D464E448958FF029617A560962"><enum>(B)</enum><header>Screening by
			 Health Insurance Exchanges</header><text>In the case of individuals enrolling
			 in a qualified health plan through a Health Insurance Exchange under title I of
			 the Patient Protection and Affordable Care Act, the Exchange shall provide (at
			 the time of enrollment) for a screening of the individual to determine if the
			 individual is a qualified resident for purposes of the America Rx program.</text>
					</subparagraph></paragraph><paragraph id="H1FC2EA820CB24CFDAFBB71021106B6B5"><enum>(3)</enum><header>Relation to
			 other coverage</header><text>In order not to discourage employers and health
			 insurance issuers from providing comprehensive prescription drug coverage
			 through a group health plan or health insurance coverage, no such employer or
			 issuer may participate in a Health Insurance Exchange if the Secretary
			 determines that the prescription drug benefits under the plan or coverage have
			 been reduced as a result of the America Rx program.</text>
				</paragraph><paragraph id="H78A8C1A0EB77480194EA7D602FD52663"><enum>(4)</enum><header>Protection of
			 the low income</header><text>Nothing in this section shall be construed as
			 reducing the prescription drug benefits available to low-income individuals, as
			 well as senior citizens and the disabled, under the Medicare or Medicaid
			 programs as a result of the implementation of the America Rx program.</text>
				</paragraph></subsection><subsection id="HAACB01E8DA5E4891AC64B476151BE01C"><enum>(e)</enum><header>Arrangements
			 with participating pharmacies</header>
				<paragraph id="HF96533958C83436C8D913DD9308EB01A"><enum>(1)</enum><header>In
			 general</header><text>Under the America Rx program arrangements are made with
			 pharmacies for the provision of prescription drugs at discounted prices to
			 qualified residents in a reasonably accessible manner. Such arrangements shall
			 provide that—</text>
					<subparagraph id="HCF7DD2D1D27841A7B913AA1E0292F366"><enum>(A)</enum><text>each participating
			 pharmacy shall—</text>
						<clause id="HF0BF033F5D234338A93BE05D07DF7B1E"><enum>(i)</enum><text>provide discounts
			 on prices for outpatient prescription drugs for qualified residents in return
			 for prompt reimbursement of the amount of such discounts and a reasonable
			 dispensing fee;</text>
						</clause><clause id="H0715583AAAE64829B821335AD48B7E5D"><enum>(ii)</enum><text>not
			 charge qualified residents more (before such discounts) for outpatient
			 prescription drugs than the amount that individuals who are not qualified
			 residents are charged for such drugs; and</text>
						</clause><clause id="HE5E81865AE8F4259AB35ABE717837F1E"><enum>(iii)</enum><text>report to the
			 Secretary (or the Secretary’s designee) information regarding the discounts
			 provided and fees incurred; and</text>
						</clause></subparagraph><subparagraph id="HCD551E73649A49E6B0F2A7962395F36A"><enum>(B)</enum><text>the program
			 shall—</text>
						<clause id="HB1819399C15941D1B9B747A29243BA4D"><enum>(i)</enum><text>ensure the
			 reasonable and timely payment to a participating retail pharmacy on a prompt
			 basis (no less promptly than as provided under the Medicare program) for
			 discounted prices provided to qualified residents under the program and for
			 reasonable dispensing fees; and</text>
						</clause><clause id="HE83E383E2176471DAEFF1967C7B10F5B"><enum>(ii)</enum><text>not
			 impose any additional fees on such pharmacies in connection with participation
			 in the program.</text>
						</clause></subparagraph></paragraph><paragraph id="H825EA15FFEB94F46B14C78BBBF624C1C"><enum>(2)</enum><header>Discounted
			 prices</header><text>The amount of the discount provided to enrolled qualifying
			 residents shall reflect the amount of rebates obtained, reduced by expenses
			 relating to administrative costs of the Federal and State governments and of
			 participating pharmacies.</text>
				</paragraph></subsection><subsection id="HF43F8171325B4BCE9F326C2DED48E81F"><enum>(f)</enum><header>Definitions</header><text>For
			 purposes of this section:</text>
				<paragraph id="HC27EF893C1BE49148C4A7A2942D1D476"><enum>(1)</enum><text>The term
			 <term>Health Insurance Exchange</term> means such an Exchange as established
			 and operated under part 3 of subtitle D of title I of the Patient Protection
			 and Affordable Care Act.</text>
				</paragraph><paragraph id="HD0FD2EC3C07C48C2A29172AA8C8DA57B"><enum>(2)</enum><text>The term
			 <term>manufacturer</term> has the meaning given such term in section 1927(k)(5)
			 of the <act-name parsable-cite="SSA">Social Security Act</act-name> (42 U.S.C.
			 1396r–8(k)(5)).</text>
				</paragraph><paragraph id="H5711A6BCB53C4802B82EFA46DD81FCC3"><enum>(3)</enum><text>The term
			 <term>Medicaid program</term> means a State program under title XIX of the
			 <act-name parsable-cite="SSA">Social Security Act</act-name>, including such a
			 program operating under a Statewide waiver under section 1115 of such
			 Act.</text>
				</paragraph><paragraph id="H881395DE1E0F4E4B93B92725E181B622"><enum>(4)</enum><text>The term
			 <term>outpatient prescription drug</term> has the meaning given the term
			 <term>covered outpatient drug</term> in section 1927(k)(2) of the
			 <act-name parsable-cite="SSA">Social Security Act</act-name> (42 U.S.C.
			 1396r–8(k)(2)).</text>
				</paragraph><paragraph id="HDE4EF13A03824ED4BD5C9A01D8062FBA"><enum>(5)</enum><text>The term
			 <term>Secretary</term> means the Secretary of Health and Human Services.</text>
				</paragraph><paragraph id="H1FB52DF85EC54D038AD0A6297D4D36E3"><enum>(6)</enum><text>The term
			 <term>State</term> has the meaning given such term for purposes of title XIX of
			 the <act-name parsable-cite="SSA">Social Security Act</act-name>.</text>
				</paragraph></subsection></section></legis-body>
</bill>
